Abstract:Osteoarthritis (OA) is a painful and disabling musculoskeletal disorder, with a large impact on the global population, resulting in several limitations on daily activities. In OA, inflammation is frequent and mainly controlled through inflammatory cytokines released by immune cells. These outbalanced inflammatory cytokines cause cartilage extracellular matrix (ECM) degradation and possible growth of neuronal fibers into subchondral bone triggering pain. Even though pain is the major symptom of musculoskeletal diseases, there are still no effective treatments to counteract it and the mechanisms behind these pathologies are not fully understood. Thus, there is an urgent need to establish reliable models for assessing the molecular mechanisms and consequently new therapeutic targets. Models have been established to support this research field by providing reliable tools to replicate the joint tissue in vitro . Studies firstly started with simple 2D culture setups, followed by 3D culture focusing mainly on cell-cell interactions to mimic healthy and inflamed cartilage. Cellular approaches were improved by scaffold-based strategies to enhance cell-matrix interactions as well as contribute to developing mechanically more stable in vitro models. The progression of the cartilage tissue engineering would then profit from the integration of 3D bioprinting technologies as these provide 3D constructs with versatile structural arrangements of the 3D constructs. The upgrade of the available tools with dynamic conditions was then achieved using bioreactors and fluid systems. Finally, the organ-on-a-chip encloses all the state of the art on cartilage tissue engineering by incorporation of different microenvironments, cells and stimuli and pave the way to potentially simulate crucial biological, chemical, and mechanical features of arthritic joint. In this review, we describe the several available tools ranging from simple cartilage pellets to complex organ-on-a-chip platforms, including 3D tissue-engineered constructs and bioprinting tools. Moreover, we provide a fruitful discussion on the possible upgrades to enhance the in vitro systems making them more robust regarding the physiological and pathological modeling of the joint tissue/OA.

Human Organ-on-a-Chip Microphysiological Systems to Model Musculoskeletal Pathologies and Accelerate Therapeutic Discovery

Microphysiological systems to advance human pathophysiology and translational medicine

Three-dimensional osteogenic and chondrogenic systems to model osteochondral physiology and degenerative joint diseases

Musculoskeletal Organs‐on‐chips: An Emerging Platform for Studying the Nanotechnology‐Biology Interface

Organoids of Musculoskeletal System for Disease Modeling, Drug Screening, and Regeneration

Cardiac Meets Skeletal: What’s New in Microfluidic Models for Muscle Tissue Engineering

Microphysiological Constructs and Systems: Biofabrication Tactics, Biomimetic Evaluation Approaches, and Biomedical Applications

An Engineered Anisotropic Skeletal Muscle Organoid‐on‐a‐Chip for Deciphering Muscle Response under Intermittent Hypoxia

Basic models to advanced systems: harnessing the power of organoids-based microphysiological models of the human brain

Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges

Cutting-Edge Technologies for Inflamed Joints on Chip: How Close Are We?

Osteochondral Tissue-On-a-Chip: A Novel Model for Osteoarthritis Research

Modular Microphysiological System for Modeling of Biologic Barrier Function

Strategic Approaches in Generation of Robust Microphysiological 3D Musculoskeletal Tissue System

Synovial joint-on-a-chip for modeling arthritis: progress, pitfalls, and potential

Latest developments in engineered skeletal muscle tissues for drug discovery and development

Biological and medical applications of a brain-on-a-chip

Mechanical Stimulation: A Crucial Element of Organ-on-Chip Models

Biomimetic Cardiac Microsystems for Pathophysiological Studies and Drug Screens

Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development

Advances and challenges in organ-on-chip technology: toward mimicking human physiology and disease in vitro